Price:
Rs. 847.00
Sample Type: Blood
Fasting Not Required
Booking Procedure:
- Technician from Thyrocare will be assigned for a free home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
- Soft copy reports will be sent to your email address within 24 to 48 hours.
Frequently Asked Questions (FAQ's):
1. What is included in the Thyrocare CA 15-3 Test?
The Thyrocare CA 15-3 Test measures the level of Cancer Antigen 15-3, a protein often elevated in breast cancer patients. It is primarily used as a tumor marker to monitor disease progression, treatment response, or recurrence in individuals with breast cancer.
2. Who should opt for the Thyrocare CA 15-3 Test?
This test is recommended for individuals who have been diagnosed with breast cancer and are undergoing treatment or follow-up. It helps assess how well the treatment is working and detects possible recurrence or metastasis.
3. Is fasting required before taking the Thyrocare CA 15-3 Test?
No fasting is required. The test can be performed at any time of the day as advised by your physician.
4. How is the sample collected for the Thyrocare CA 15-3 Test?
A certified phlebotomist will collect a blood sample from your home. The sample is tested using advanced immunoassay technology in Thyrocare’s NABL- and ISO-certified labs. We provide home sample collection and a digital report.
5. What is the cost of the Thyrocare CA 15-3 Test?
The test is priced at RS 847.
6. When will I receive my Thyrocare test reports?
You will receive your test report within 10 to 24 hours after sample collection via SMS and email.
7. Is the Thyrocare CA 15-3 Test available across India?
Yes, the test is available pan India, including urban, semi-urban, and rural locations through our extensive home collection network.
8. What makes the Thyrocare CA 15-3 Test reliable?
Thyrocare ensures high accuracy and reliability through the use of automated equipment, international quality standards, and centralized processing systems designed specifically for cancer marker evaluations.